Texas Advances First Round of New Medical Marijuana Licenses Under Expanded Compassionate Use Program

Texas regulators have announced the nine applicants that are moving forward in the first phase of the expanded Texas Compassionate Use Program licensing process.

The Department of Public Safety announced that these businesses will receive conditional approval while they undergo a deeper review of their backgrounds, finances and regulatory compliance.

The companies advancing include:

Their conditional status does not allow them to cultivate, manufacture or sell medical marijuana until the department completes its due diligence review and signs off on the final licenses.

DPS said each applicant will be required to meet every statutory and regulatory obligation attached to TCUP licensing. Officials noted they will request additional materials from all nine organizations before determining whether they qualify for full authorization. No licensing fees will be collected until those evaluations are complete, and the agency cautioned that conditional approval does not guarantee these businesses will ultimately be cleared to operate.

Under House Bill 46, the department will award 12 new licenses in two phases—nine in this first round and three more by April 1, 2026. The expansion follows earlier legislative changes that broadened TCUP, a program first created in 2015 under Senate Bill 339. DPS oversees the Compassionate Use Registry of Texas, which tracks physicians authorized to prescribe low-THC marijuana for patients with certain medical conditions, and it conducts recurring inspections of licensed dispensing organizations to ensure ongoing compliance with state law.